Ketamine 10mg/mL injection shortage
19th March 2018
Pfizer is currently experiencing supply problems with Ketalar (ketamine) 10mg/mL injection the UK. It is anticipated to be out of stock from the end of March until the end of April 2018. Supplies of the 50mg/mL product are unaffected and will remain available during this time. There is no other alternative authorized UK supplier.
RPS consultation on safe and secure handling of medicines
14th March 2018
The Royal Pharmaceutical Society (RPS) is consulting on proposed multidisciplinary guidance which considers the processes associated with the physical handling of medicines (including obtaining, storage, transport, manufacture or manipulation, removal and disposal), It includes relevant aspects of the Nursing and Midwifery Councils standards for medicines management, specifically sections on administration and transcription. All health professionals working across all sectors of care are encouraged to respond. The consultation period closes on 20 April 2018.
IASP statement on appropriate use of opioids
12th March 2018
The International Association for the Study of Pain (IASP) has produced a position statement on opioids to guide appropriate use.
PCF6 book in demand!
8th March 2018
Demand for PCF6 print version has been high and has exhausted stocks on two occasions and we have today ordered a third print run. Although we have attempted to maintain a consistent supply, issues out of our control have led to delays developing between order placement and order fulfilment.
We apologise for any inconvenience caused and would like to reassure members that all current orders will be dealt with as soon as possible. If you are awaiting an order, you will be e-mailed when your book has been despatched.
We have only one part-time administrator to deal with all the orders and we are grateful for your patience and ongoing support.
Recent news
- RPS Wales Palliative and End of Life Care Policy
- NICE guidelines for COPD updated
- AWMSG approves tiotropium
- Palliative Care Formulary migration to MedicinesComplete - January 2019
- Supplementary information on cannabis-based products for medicinal use
- Report on action taken on ambulatory syringe drivers
- NICE consultation on cannabis-based products for medicinal use
- Guidance and information on prescribing and supply of cannabis-based products for medicinal use
- Instanyl (fentanyl) multidose nasal sprays discontinued
- Gabapentin and pregabalin to be controlled as class C drugs
News archive
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000